Maximum quantity allowed is 999
Please select the quantity
CAS RN: 609799-22-6 | Product Number: T3813
Tasimelteon
×
![]()
×
Purity: >98.0%(HPLC)
Synonyms:
- N-[[(1R,2R)-2-(2,3-Dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide
Product Documents:
| Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time |
Shipping Information
|
|---|---|---|---|---|---|
| 10MG |
$81.00
|
6 | 1 | Contact Us | |
| 50MG |
$285.00
|
6 | 0 | Contact Us |
* Please contact our distributors or
TCI
to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.
| Product Number | T3813 |
| Purity / Analysis Method | >98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__1__5H__1__9NO__2 = 245.32 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Refrigerated (0-10°C) |
| Condition to Avoid | Heat Sensitive |
| CAS RN | 609799-22-6 |
| Reaxys Registry Number | 15439325 |
| PubChem Substance ID | 468592958 |
| MDL Number | MFCD09033789 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Elemental analysis(Nitrogen) | 5.30 to 6.10 % |
| Specific rotation [a]20/D | -41.0 to -46.0 deg(C=1, CHCL3) |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 78 °C |
| Specific Rotation | -45° (C=1,CHCl3) |
GHS
Related Laws:
| RTECS# | TX1450577 |
Transport Information:
| H.S.code* | 2932.99-000 |
Application
Tasimelteon: A Selective Melatonin MT1 and MT2 Receptors Agonist
Tasimelteon (BMS-214778) is a melatonin [M1105] receptor agonist with both high affinity for melatonin MT1 and MT2 receptors, similar to other members of the melatonin receptor agonist including ramelteon [R0216] and agomelatine [A2606]. Characteristically, tasimelteon exhibits a greater affinity for the MT2 as compared to the MT1 receptor. The agonist activity at the MT1 and MT2 receptors has been reported to contribute to its sleep-promoting properties. And then, tasimelteon currently is approved in the United States and the EU for the treatment of the treatment of non-24-hour sleep-wake disorder. (The product is for research purpose only.)
References
- Preclinical pharmacokinetics and metabolism of BMS-214778, a novel melatonin receptor agonist
- Tasimelteon, a melatonin agonist for the treatment of insomnia and circadian rhythm sleep disorders (a review)
- Tasimelteon: a selective and unique receptor binding profile
- Tasimelteon: first global approval (a review)
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.